Jing Li
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 2%
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 30
- Thyroid Disorders and Treatments 27
-
- Cancer-related molecular mechanisms research 26
- MicroRNA in disease regulation 20
- Co-authors
- Xiaoyi HuMaorong FuWei WangXia ZhaoZhongyan ShanWeiping TengChangning LiuRobert W. McMurray
- Journals
- Scientific Reports (7 papers)PLoS ONE (6 papers)Oncotarget (6 papers)Frontiers in Endocrinology (5 papers)International Immunopharmacology (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jing Li
301 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Cancer Research 1.4k
- Immunology 1.1k
- Endocrinology, Diabetes and Metabolism 788
- Molecular Biology 2.6k
- Oncology 1.0k
Countries citing papers authored by Jing Li
This map shows the geographic impact of Jing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Li more than expected).
Fields of papers citing papers by Jing Li
This network shows the impact of papers produced by Jing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Li. The network helps show where Jing Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 13 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 14 | |
| 12 | 2023 | 10 | |
| 13 | Risk Factors of Deterioration in Quality of Life Scores in Thyroid Cancer Patients After Thyroidectomy | 2019 | 1 |
| 14 | The Therapeutic Effect of Melatonin on GC by Inducing Cell Apoptosis and Autophagy Induced by Endoplasmic Reticulum Stress | 2019 | 1 |
| 15 | 2018 | 14 | |
| 16 | 2018 | 4 | |
| 17 | 2018 | 6 | |
| 18 | The contribution of thyroid autoimmunity to miscarriage in euthyroid women. | 2016 | 3 |
| 19 | 2015 | 20 | |
| 20 | 2014 | 13 |
About Jing Li
Jing Li is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Pathology and Forensic Medicine, Obstetrics and Gynecology and Genetics, having authored 326 papers that have together received 6.9k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (30 papers), Thyroid Disorders and Treatments (27 papers), Cancer-related molecular mechanisms research (26 papers), MicroRNA in disease regulation (20 papers), Estrogen and related hormone effects (19 papers), Circular RNAs in diseases (15 papers), RNA modifications and cancer (13 papers) and Cytokine Signaling Pathways and Interactions (13 papers). The work is most often cited by research in Cancer Research (1.4k citations), Immunology (1.1k citations), Endocrinology, Diabetes and Metabolism (788 citations), Molecular Biology (2.6k citations) and Oncology (1.0k citations). Jing Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiaoyi Hu, Maorong Fu, Wei Wang, Xia Zhao, Zhongyan Shan, Weiping Teng, Changning Liu, Robert W. McMurray, Jane F. Reckelhoff and Babbette LaMarca. Their work appears in journals such as Scientific Reports, PLoS ONE, Oncotarget, Frontiers in Endocrinology and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.